Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH.

Endocrinology. 2005 Feb;146(2):685-93. Epub 2004 Nov 11.

PMID:
15539550
2.

[Effect of SSRIs on bone metabolism].

Kerbage H, Bahadori S, Léger J, Carel JC, Purper Ouakil D.

Encephale. 2014 Feb;40(1):56-61. doi: 10.1016/j.encep.2013.04.007. Epub 2013 Jun 28. Review. French.

PMID:
23810751
3.

Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency.

Warden SJ, Nelson IR, Fuchs RK, Bliziotes MM, Turner CH.

Menopause. 2008 Nov-Dec;15(6):1176-83. doi: 10.1097/gme.0b013e318173566b.

PMID:
18725867
4.

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.

Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA.

Science. 2004 Oct 29;306(5697):879-81.

5.

Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130.

Taber MT, Wright RN, Molski TF, Clarke WJ, Brassil PJ, Denhart DJ, Mattson RJ, Lodge NJ.

Pharmacol Biochem Behav. 2005 Mar;80(3):521-8.

PMID:
15740795
6.

Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos.

Amireault P, Dubé F.

Biol Reprod. 2005 Aug;73(2):358-65. Epub 2005 Apr 27.

PMID:
15858217
7.

Serotonin regulates osteoclast differentiation through its transporter.

Battaglino R, Fu J, Späte U, Ersoy U, Joe M, Sedaghat L, Stashenko P.

J Bone Miner Res. 2004 Sep;19(9):1420-31. Epub 2004 Jun 21.

9.

Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels.

Warden SJ, Hassett SM, Bond JL, Rydberg J, Grogg JD, Hilles EL, Bogenschutz ED, Smith HD, Fuchs RK, Bliziotes MM, Turner CH.

Bone. 2010 Apr;46(4):985-92. doi: 10.1016/j.bone.2009.12.031. Epub 2010 Jan 6.

10.

Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.

Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, Eddahibi S.

Am J Respir Crit Care Med. 2003 Aug 15;168(4):487-93. Epub 2003 May 28.

PMID:
12773327
12.

Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.

Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, Hamon M, Lanfumey L.

J Neurosci. 2001 Mar 15;21(6):2178-85.

14.

Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.

Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP.

Eur J Neurosci. 2000 Jul;12(7):2299-310.

PMID:
10947809
15.

Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.

Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y, Hashimoto H, Yamada S.

Br J Pharmacol. 2005 Mar;144(5):695-702.

16.
17.

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch KP.

Mol Pharmacol. 1998 Apr;53(4):649-55.

18.

Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background.

Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN.

Genes Brain Behav. 2003 Dec;2(6):365-80.

19.

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.

Lotrich FE, Pollock BG, Ferrell RE.

Am J Pharmacogenomics. 2001;1(3):153-64. Review.

PMID:
12083964
20.

Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.

David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L.

Eur J Pharmacol. 2004 May 10;492(1):41-8.

PMID:
15145704

Supplemental Content

Support Center